ARCHIVES

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

This article is from The Cancer Letter archive.

Vol. 40 No. 12 | March 21, 2014

Download PDF Visit The Full Archive

Related Articles

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

NCI-Approved Clinical Trials

October 29, 2004

Bristol-Myers Cancer Scientist Award Nominations To Close March 1

February 24, 1978